NDC 68475-514-01 - Hydralazine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68475-514
- Requested NDC
- 68475-514-01
- Package NDCs from labels
- 68475-514-01, 68475-514-02
- Manufacturer
- Navinta LLC
- Effective date
- 2026-04-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydralazine Hydrochloride - Navinta LLC | Navinta LLC | 2026-04-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68475-514-01 | Hydralazine Hydrochloride | 1 mL in 1 VIAL | INJECTION | 1 | 2 | |
| 68475-514-02 | Hydralazine Hydrochloride | 25 in 1 PACKAGE | INJECTION | 25 | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | American Regent, Inc. | 17210abc-58f6-442e-8ff2-7971333c82f6 | 2019-05-06 | Warnings, Adverse reactions | 966571 FD171B778Y |
| Dynamic Eyewash with Eyecup | WATER | Dynamic Safety International | 7d3af0f4-0e1f-9ea5-e053-2991aa0af7a2 | 2018-12-17 | Warnings | 059QF0KO0R |
| Bio Rock Water | ROCK WATER | BioActive Nutritional, Inc. | 178bd16d-0d4f-49d8-866b-8ab3a3c6889d | 2018-07-30 | Warnings | 059QF0KO0R |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Ascend Laboratories, LLC | e7bfec3d-5222-4a26-8f99-6c2a28e14aa6 | 2017-12-28 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | bfbd5960-ae6b-46f5-adfa-e330d7a21dfa | 2017-12-21 | Warnings, Adverse reactions | FD171B778Y |
| Sterile Water | WATER | Baxter Healthcare Corporation | ef3e79c5-3f58-4b36-a296-64b7d9a651c1 | 2017-10-17 | Warnings, Adverse reactions | 059QF0KO0R |
| Eye Wash | WATER | CVS Pharmacy | 049cee29-7ec2-4d5b-8308-f522acde43a7 | 2017-03-29 | Warnings | 059QF0KO0R |
| HydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 921c8693-84c2-4313-a2a6-ab3be637d554 | 2016-07-14 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | d9892176-d4a6-4edb-92b9-5f56243f3d22 | 2016-06-13 | Warnings, Adverse reactions | FD171B778Y |
| Sterile Water | WATER | Baxter Healthcare Company | 210dc9ab-d6ca-4552-ac19-1be17792d290 | 2016-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | ddbbdb09-3202-42d7-bbb0-08331dde2f54 | 2016-02-29 | Warnings, Adverse reactions | FD171B778Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.